Louise Rodino-Klapac - 04 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Head of R&D, CSO
Signature: /s/ Cristin Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac
Issuer symbol: SRPT
Transactions as of: 04 Mar 2025
Net transactions value: -$172,683
Form type: 4
Filing time: 06 Mar 2025, 20:00:03 UTC
Previous filing: 04 Mar 2025
Next filing: 10 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Tax liability	$172,683	-1,704	-2.5%	$101.34	65,322	04 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.